Oncodesign: Funding, Investors & Team (Oct 2026)
Oncodesign is a unique oncology preclinical Contract Research Organization (CRO) that specializes in providing pharmacological expertise for anticancer therapies. Founded in 1995, Oncodesign fills the gaps in innovation within the healthcare industry by utilizing its precision medicine platform. This platform incorporates technological innovation and includes activities such as Etiology, Discovery, and Experimentation. By employing these methods, Oncodesign aims to develop a more effective approach to combating innate and acquired resistance in cancer treatments, ultimately reducing therapeutic failures. Oncodesign collaborates with big pharmaceutical companies, biotech firms, public research institutions, and investment groups to drive the research and development of new therapeutic and diagnostic tools. With a range of services, partnerships, and licensing programs, Oncodesign is capable of meeting various innovation needs. Furthermore, the company is listed on the Euronext Growth Paris market and has a stable ownership structure, with a majority owner dedicated to its growth.
Oncodesign has raised $6.3M across 1 funding round on record, the most recent an undisclosed round of $6.3M announced in Oct 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oncodesign Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Oncodesign Funding Rounds
Oncodesign Founders and Leadership Team
No contact details are on record for this team yet.
Oncodesign Funding Compared to Other Biotechnology Startups
Oncodesign's latest round of $6.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oncodesign in Biotechnology and Dijon
Companies Similar to Oncodesign
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
Oncodesign Funding FAQs
What does Oncodesign do?
Oncodesign is a unique oncology preclinical Contract Research Organization (CRO) that specializes in providing pharmacological expertise for anticancer therapies. Founded in 1995, Oncodesign fills the gaps in innovation within the healthcare industry by utilizing its precision medicine platform. This platform incorporates technological innovation and includes activities such as Etiology, Discovery, and Experimentation. By employing these methods, Oncodesign aims to develop a more effective approach to combating innate and acquired resistance in cancer treatments, ultimately reducing therapeutic failures. Oncodesign collaborates with big pharmaceutical companies, biotech firms, public research institutions, and investment groups to drive the research and development of new therapeutic and diagnostic tools. With a range of services, partnerships, and licensing programs, Oncodesign is capable of meeting various innovation needs. Furthermore, the company is listed on the Euronext Growth Paris market and has a stable ownership structure, with a majority owner dedicated to its growth.
How much funding has Oncodesign raised?
Oncodesign has raised $6.3M across 1 round on record. The most recent is an undisclosed round of $6.3M announced in Oct 2023.
When did Oncodesign last raise funding?
Oncodesign's most recent funding round on record is an undisclosed round of $6.3M, announced in Oct 2023.
Who is the CEO of Oncodesign?
Philippe Genne is listed as CEO at Oncodesign.
Where is Oncodesign headquartered?
Oncodesign is based in Dijon, Bourgogne, France.
How many employees does Oncodesign have?
Oncodesign is in the 101-250 employee band.
How does Oncodesign's funding compare to other Biotechnology startups?
Oncodesign's latest round of $6.3M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Oncodesign Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncodesign is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.